124 related articles for article (PubMed ID: 20494582)
1. Novel analogues of Istaroxime, a potent inhibitor of Na(+),K(+)-ATPase: Synthesis, structure-activity relationship and 3D-quantitative structure-activity relationship of derivatives at position 6 on the androstane scaffold.
Gobbini M; Armaroli S; Banfi L; Benicchio A; Carzana G; Ferrari P; Giacalone G; Marazzi G; Moro B; Micheletti R; Sputore S; Torri M; Zappavigna MP; Cerri A
Bioorg Med Chem; 2010 Jun; 18(12):4275-99. PubMed ID: 20494582
[TBL] [Abstract][Full Text] [Related]
2. Novel analogues of istaroxime, a potent inhibitor of Na+,K+-ATPase: synthesis and structure-activity relationship.
Gobbini M; Armaroli S; Banfi L; Benicchio A; Carzana G; Fedrizzi G; Ferrari P; Giacalone G; Giubileo M; Marazzi G; Micheletti R; Moro B; Pozzi M; Scotti PE; Torri M; Cerri A
J Med Chem; 2008 Aug; 51(15):4601-8. PubMed ID: 18637667
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design and synthesis of novel potent Na+,K+ -ATPase inhibitors derived from a 5alpha,14alpha-androstane scaffold as positive inotropic compounds.
De Munari S; Cerri A; Gobbini M; Almirante N; Banfi L; Carzana G; Ferrari P; Marazzi G; Micheletti R; Schiavone A; Sputore S; Torri M; Zappavigna MP; Melloni P
J Med Chem; 2003 Aug; 46(17):3644-54. PubMed ID: 12904068
[TBL] [Abstract][Full Text] [Related]
4. Istaroxime, a novel luso-inotropic agent for the treatment of acute heart failure.
Wehrens XH
Curr Opin Investig Drugs; 2007 Sep; 8(9):769-77. PubMed ID: 17729189
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, cardiotonic activity, and structure-activity relationships of 17 beta-guanylhydrazone derivatives of 5 beta-androstane-3 beta, 14 beta-diol acting on the Na+,K(+)-ATPase receptor.
Cerri A; Serra F; Ferrari P; Folpini E; Padoani G; Melloni P
J Med Chem; 1997 Oct; 40(21):3484-8. PubMed ID: 9341924
[TBL] [Abstract][Full Text] [Related]
6. A new approach to the design of novel inhibitors of Na+,K+-ATPase: 17alpha-substituted seco-D 5beta-androstane as cassaine analogues.
De Munari S; Barassi P; Cerri A; Fedrizzi G; Gobbini M; Mabilia M; Melloni P
J Med Chem; 1998 Jul; 41(16):3033-40. PubMed ID: 9685243
[TBL] [Abstract][Full Text] [Related]
7. 17beta-O-Aminoalkyloximes of 5beta-androstane-3beta,14beta-diol with digitalis-like activity: synthesis, cardiotonic activity, structure-activity relationships, and molecular modeling of the Na(+),K(+)-ATPase receptor.
Cerri A; Almirante N; Barassi P; Benicchio A; Fedrizzi G; Ferrari P; Micheletti R; Quadri L; Ragg E; Rossi R; Santagostino M; Schiavone A; Serra F; Zappavigna MP; Melloni P
J Med Chem; 2000 Jun; 43(12):2332-49. PubMed ID: 10882359
[TBL] [Abstract][Full Text] [Related]
8. Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial.
Shah SJ; Blair JE; Filippatos GS; Macarie C; Ruzyllo W; Korewicki J; Bubenek-Turconi SI; Ceracchi M; Bianchetti M; Carminati P; Kremastinos D; Grzybowski J; Valentini G; Sabbah HN; Gheorghiade M;
Am Heart J; 2009 Jun; 157(6):1035-41. PubMed ID: 19464414
[TBL] [Abstract][Full Text] [Related]
9. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
Paula S; Tabet MR; Ball WJ
Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of novel sodium/potassium-ATPase inhibitors by virtual screening of a compound database.
Stanton DT; Ankenbauer J; Rothgeb D; Draper M; Paula S
Bioorg Med Chem; 2007 Sep; 15(18):6062-70. PubMed ID: 17618121
[TBL] [Abstract][Full Text] [Related]
11. Istaroxime, a stimulator of sarcoplasmic reticulum calcium adenosine triphosphatase isoform 2a activity, as a novel therapeutic approach to heart failure.
Micheletti R; Palazzo F; Barassi P; Giacalone G; Ferrandi M; Schiavone A; Moro B; Parodi O; Ferrari P; Bianchi G
Am J Cardiol; 2007 Jan; 99(2A):24A-32A. PubMed ID: 17239701
[TBL] [Abstract][Full Text] [Related]
12. A QSAR study on a series of simplified digitalis-like compounds acting on Na+,K(+)-ATPase.
Seelam J; Satuluri VS; Gupta SP; Anwer Z
Indian J Biochem Biophys; 2011 Jun; 48(3):158-63. PubMed ID: 21793306
[TBL] [Abstract][Full Text] [Related]
13. Istaroxime: a new luso-inotropic agent for heart failure.
Mattera GG; Lo Giudice P; Loi FM; Vanoli E; Gagnol JP; Borsini F; Carminati P
Am J Cardiol; 2007 Jan; 99(2A):33A-40A. PubMed ID: 17239702
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of the novel inotropic agent (E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride (PST2744).
Micheletti R; Mattera GG; Rocchetti M; Schiavone A; Loi MF; Zaza A; Gagnol RJ; De Munari S; Melloni P; Carminati P; Bianchi G; Ferrari P
J Pharmacol Exp Ther; 2002 Nov; 303(2):592-600. PubMed ID: 12388640
[TBL] [Abstract][Full Text] [Related]
15. 17 alpha-O-(aminoalkyl)oxime derivatives of 3 beta,14 beta-dihydroxy-5 beta-androstane and 3 beta-hydroxy-14-oxoseco-D-5 beta-androstane as inhibitors of Na(+),K(+)-ATPase at the digitalis receptor.
Gobbini M; Barassi P; Cerri A; De Munari S; Fedrizzi G; Santagostino M; Schiavone A; Torri M; Melloni P
J Med Chem; 2001 Nov; 44(23):3821-30. PubMed ID: 11689068
[TBL] [Abstract][Full Text] [Related]
16. Diverse toxicity associated with cardiac Na+/K+ pump inhibition: evaluation of electrophysiological mechanisms.
Rocchetti M; Besana A; Mostacciuolo G; Ferrari P; Micheletti R; Zaza A
J Pharmacol Exp Ther; 2003 May; 305(2):765-71. PubMed ID: 12606646
[TBL] [Abstract][Full Text] [Related]
17. Imidazopyridines: roles of pyridine nitrogen position and methylsulfinyl oxygen for in vitro positive inotropic mechanism and chronotropic activity.
Honerjäger P; Klockow M; Schönsteiner G; Jonas R
J Cardiovasc Pharmacol; 1989 May; 13(5):673-81. PubMed ID: 2472514
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of the Na+, K+-ATPase digitalis binding site.
Keenan SM; DeLisle RK; Welsh WJ; Paula S; Ball WJ
J Mol Graph Model; 2005 Jun; 23(6):465-75. PubMed ID: 15886034
[TBL] [Abstract][Full Text] [Related]
19. Combining SERCA2a activation and Na-K ATPase inhibition: a promising new approach to managing acute heart failure syndromes with low cardiac output.
Gheorghiade M; Ambrosy AP; Ferrandi M; Ferrari P
Discov Med; 2011 Aug; 12(63):141-51. PubMed ID: 21878191
[TBL] [Abstract][Full Text] [Related]
20. Modulation of sarcoplasmic reticulum function by Na+/K+ pump inhibitors with different toxicity: digoxin and PST2744 [(E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride].
Rocchetti M; Besana A; Mostacciuolo G; Micheletti R; Ferrari P; Sarkozi S; Szegedi C; Jona I; Zaza A
J Pharmacol Exp Ther; 2005 Apr; 313(1):207-15. PubMed ID: 15576469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
